loading

Advanced Long-Acting Therapy for Equine Joint Health


Arthramid® is a clinically validated, long-acting intra-articular treatment designed to improve joint health, restore mobility, and enhance performance in horses affected by osteoarthritis and joint-related lameness.
Backed by more than 25 years of scientific research, Arthramid® supports long-term joint function by integrating into the synovial membrane and addressing inflammation at its source.


Why Arthramid® Makes a Difference


Arthramid® works differently from conventional joint therapies. Rather than providing temporary lubrication or short-term inflammation control, it strengthens synovial membrane integrity and restores joint capsule elasticity—helping slow disease progression.


Key Clinical Benefits

  • Demonstrated reduction in lameness across early and advanced stages of osteoarthritis
  • Long-lasting therapeutic effect, frequently extending beyond 12 months
  • Targets synovitis, a primary driver of joint degeneration
  • Supported by peer-reviewed clinical research in both veterinary and human medicine
  • Designed to support joint comfort without compromising cartilage health
Images

Which Horses Benefit Most from Arthramid®

Images
Early-Stage Joint Support

Ideal for horses with synovitis or early osteoarthritis, before irreversible cartilage damage occurs.

Images
Advanced Osteoarthritis Management

Suitable for cases that show limited response to corticosteroids, hyaluronic acid, IRAP, or other conventional therapies.

Images
Performance & Competition Horses

Minimal withdrawal considerations make Arthramid® a reliable option for sport horses across all disciplines.

Images

One Health Innovation: From Human Medicine to Equine Care

Arthramid® utilizes 2.5% iPAAG technology, originally developed for human osteoarthritis treatment and now successfully adapted for veterinary use.

This One Health approach bridges advancements in human and animal medicine, ensuring the highest scientific standards in joint care. Ongoing academic research continues to expand understanding of iPAAG’s mechanism of action across species.

Your Trusted GCC Partner

Arthramid® by THESAY Veterinary

As the exclusive supplier of Arthramid® in the GCC, THESAY Veterinary is committed to delivering innovative, evidence-based solutions that elevate equine healthcare standards across the region.